Title |
Guidelines for treatment of immune-mediated cerebellar ataxias
|
---|---|
Published in |
Cerebellum & Ataxias, November 2015
|
DOI | 10.1186/s40673-015-0034-y |
Pubmed ID | |
Authors |
Hiroshi Mitoma, Marios Hadjivassiliou, Jérôme Honnorat |
Abstract |
Immune-mediated cerebellar ataxias include gluten ataxia, paraneoplastic cerebellar degeneration, GAD antibody associated cerebellar ataxia, and Hashimoto's encephalopathy. Despite the identification of an increasing number of immune-mediated cerebellar ataxias, there is no proposed standardized therapy. We evaluated the efficacies of immunotherapies in reported cases using a common scale of daily activity. The analysis highlighted the importance of removal of autoimmune triggering factors (e.g., gluten or cancer) and the need for immunotherapy evaluation (e.g., corticosteroids, intravenous immunoglobulin, immunosuppressants) and adaptation according to each subtype. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Science communicators (journalists, bloggers, editors) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 1% |
Chile | 1 | 1% |
Unknown | 97 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 18 | 18% |
Student > Ph. D. Student | 12 | 12% |
Researcher | 11 | 11% |
Student > Master | 10 | 10% |
Student > Postgraduate | 9 | 9% |
Other | 24 | 24% |
Unknown | 15 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 44 | 44% |
Neuroscience | 16 | 16% |
Agricultural and Biological Sciences | 5 | 5% |
Nursing and Health Professions | 4 | 4% |
Social Sciences | 4 | 4% |
Other | 7 | 7% |
Unknown | 19 | 19% |